January 02, 2024

On December 20, 2023, the U.S. Food and Drug Administration (FDA) reported that Busse Hospital Disposables, Inc., had recalled its tracheostomy care tray, dressing change tray, and tracheostomy care set. Busse’s recall is in direct response to Nurse Assist LLC’s, November 6, 2023, recall of its 0.9% sodium chloride irrigation USP and sterile water for irrigation USP, over sterility concerns, which is the only saline used in the Busse trays and kits.

January 01, 2024

As we embark on a new year, reflecting on important milestones can inspire us. On July 17, 1975, ONS was incorporated. In 2024, we recognize our 49th year, which means that the grand 50th anniversary is on the horizon. The planning is underway, and we cannot wait to celebrate with you.

December 28, 2023

Type 2 diabetes has been linked to an elevated risk for liver, endometrial, pancreatic, and other cancers. Furthermore, patients with diabetes and cancer have higher disease-related mortality and are at a greater risk of infections. Evidence also supports an inverse association between serum HDL cholesterol and cancer risk. To lower their blood sugar and cholesterol levels, some patients use dietary supplements such as berberine. 

December 26, 2023

Margetuximab-cmkb (Margenza®) received U.S. Food and Drug Administration approval in December 2020 for previously treated adults with metastatic HER2-positive breast cancer after clinical trials demonstrated increased progression-free and overall survival.